Business Context and Reporting Period
This Form 6-K filing by Can-Fite Biopharma Ltd. covers the period of February 2020, specifically dated February 13, 2020. The filing serves to announce a postponement of a scheduled Special Meeting of Shareholders and to provide related voting materials.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural filing regarding corporate governance and does not contain financial performance data.
Material Changes
The primary material change reported is the postponement of the Company's Special Meeting of Shareholders, which was originally scheduled for February 13, 2020. The meeting has been reconvened for Thursday, February 20, 2020, at 3:00 p.m. Israel time at the Company's offices in Petach Tikva, Israel.
Guidance, Outlook, and Management Commentary
Management commentary is limited to the logistical details of the rescheduled shareholder meeting. The filing includes the Notice and Proxy Statement, a Proxy Card for ordinary share holders, and a Voting Instruction Card for American Depositary Share holders. No financial guidance, outlook, or discussion of risks and contingencies is provided in this specific document.
Key Facts for Investor Verification
- The Special Meeting of Shareholders was postponed from February 13, 2020, to February 20, 2020.
- The new meeting time is 3:00 p.m. Israel time.
- Voting materials (Exhibits 99.1, 99.2, and 99.3) are attached to this filing for shareholders to vote in person or by proxy.
- This filing contains no financial results or operational updates.